Tag: Cancer: Breast
Industry-Led Oncology Trials May Inflate Cost-Effectiveness
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS
However, side effects differ for the two medications
SABCS: Laser Ablation May Be an Alternative Breast Cancer Tx
Procedure shows promise on tumors up to 2 cm in diameter, but more study is needed
SABCS: In Early Breast CA, Breast-Conserving Tx Beats Mastectomy
Study suggests 21 percent greater odds of survival after 10 years
Timing May Be Key to Success for Early Breast CA Treatment
Scheduling the operation as soon as possible after diagnosis seems to raise odds for survival
SABCS: Adding Capecitabine Ups Outcomes for Breast CA Patients
Linked to longer disease-free survival; second study links denosumab to reduced risk of recurrence
SABCS: β-Blockers, ACEIs May Protect Heart During Chemo
May also lower risk of complications that can interrupt breast cancer treatment
FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss
Designed for women diagnosed with breast cancer
Etiology of Leukemia in Breast Cancer Survivors Explored
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
Antidepressants Don’t Adversely Affect Tamoxifen Efficacy
No greater risk of breast cancer recurrence seen
